Literature DB >> 18931708

[Initial screening of binding-peptide of the cell surface marker CD133 of cancer stem cells].

Jin-min Sun1, Chao Zhang, Xue-nong Li.   

Abstract

OBJECTIVE: To select the binding-peptide of the cell surface marker CD133 of cancer stem cells from phage peptide library, and to find a new tool for research on stem cells, tumor therapy and anti-metastasis of cancer.
METHODS: Biotined mouse CD133 extracellular fraction was used as a target to screen phage 7-peptide library by the high affinity of streptavidin and biotin, and the clones were identified by sandwich ELISA and competitive experiment. Single strand DNA was extracted from these positive clones and was analyzed by single-strand dideoxy-sequencing.
RESULTS: After three turn solution panning, five peptides with high affinity shared the same amino acid sequence: APSPMIW and three identical peptides with high affinity shared the same amino acid sequence: LQNAPRS.
CONCLUSION: The peptides that bind with mouse CD133 extracellular fraction with high affinity and specificity were first screened from the phage peptide library for the first time, which initially indicates that the feasibility of screening from phage peptide library with small molecule polypeptide biotined as a target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931708

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  3 in total

1.  A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro.

Authors:  Jinmin Sun; Chao Zhang; Guobing Liu; Hong Liu; Chunping Zhou; Yanxia Lu; Chang Zhou; Li Yuan; Xuenong Li
Journal:  Clin Exp Metastasis       Date:  2012-01-08       Impact factor: 5.150

2.  HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

Authors:  Hang Wang; Miqing Yang; Ling Lin; Hongzhen Ren; Chaotong Lin; Suling Lin; Guoying Shen; Binfeng Ji; Chun Meng
Journal:  Cell Oncol (Dordr)       Date:  2015-12-09       Impact factor: 6.730

Review 3.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.